The IPO Buzz: LB Pharmaceuticals Upsizes IPO & Prices it at $15 – Mid-Point
LB Pharmaceuticals (LBRX) upsized its IPO at pricing to 19.0 million shares – up from 16.67 million shares in the prospectus – and priced the deal at $15.00 – the mid-point of its $14.00-to-$16.00 range – to raise $285 million on Wednesday night, Sept. 10, 2025. The clinical biotech’s stock opened Thursday, Sept. 11, at […]
September 10, 2025 Read More